ABOUT THE PARTICIPATION OF A TENGRINEWS.KZ JOURNALIST AYNASH ONDIRIS IN A CLINICAL TRIAL OF THE FIRST KAZAKHSTAN VACCINE QAZVAC
RIBSP scientists knew about the Tengrinews.kz journalist’s participation Aynash Ondiris in the article of media “180 days in the experiment: How I participated in the phase III clinical trial of…